Financial Summary (All financials)
In millions of CNY, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 936.8 | 1,206.1 | 930.0 | 1,091.8 |
Revenue growth | -22.3% | 29.7% | -14.8% | |
Cost of goods sold | 594.0 | 651.4 | 401.7 | 338.8 |
Gross profit | 342.8 | 554.8 | 528.4 | 753.0 |
Gross margin | 36.6% | 46.0% | 56.8% | 69.0% |
Sales and marketing | 38.5 | 66.9 | 75.3 | 85.0 |
General and administrative | 210.8 | 256.2 | 160.4 | 185.0 |
EBITA | -346.6 | 162.4 | 325.4 | 507.6 |
EBITA margin | -37.0% | 13.5% | 35.0% | 46.5% |
Amortization of intangibles | 5.3 | 8.5 | 6.2 | 3.0 |
EBIT | -351.9 | 153.9 | 319.3 | 504.6 |
EBIT margin | -37.6% | 12.8% | 34.3% | 46.2% |
Pre-tax income | -459.1 | 222.2 | 354.3 | 626.1 |
Income taxes | -45.6 | 108.9 | 110.5 | 189.6 |
Tax rate | 9.9% | 49.0% | 31.2% | 30.3% |
Net income | -382.2 | 117.4 | 261.3 | 442.7 |
Net margin | -40.8% | 9.7% | 28.1% | 40.5% |
|
Diluted EPS | $353,904,591.67 | $1.14 | $2.54 | $4.34 |
Shares outstanding (diluted) | 0.0 | 103.0 | 103.0 | 102.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|